Ann: US CPT Code Reimbursement for TALi Detect, page-369

I look at this and think it's got near term potential to exceed the runs of RAP and PCK. It has all the key approvals but most importantly the US reimbursement code. The revenue already exceeds that of RAP and PCK yet the MC is 30m while the others are over $200. Perhaps the addressable market is a limitation however it's far from small. If the re-rate continues then perhaps a catch up to peers is in order. At 250m MC the SP would be around 38c, certainly makes you wonder just how far this can go.



For now though this is in the hand of traders so I'm not sure the fundamentals will come into the equation too much. It will run for as long as traders can get in and out with profits, this may be up to 20-40c or it may have already peaked, always hard to tell. Reason I say this is that there are around 650m SOI yet last weeks trade transacted 1.8 billion shares, fair to say traders are in control rather than long term holders. It's interesting though, while traders come and go there are also plenty buying and holding for the longer story to unfold limiting the supply, as more and more shares go into bottom drawers the likelihood of a sustained move improves. I've free carried but retain a half decent position as I can see this going loopy in the next few months as revenue begins to step up. With the US reimbursement code in place don't be surprised if revenue steps from a few hundred k a quarter to a few million a quarter in a fairly short time.

The chart also shows that this mammoth move could still be in it's infancy